고객참여
Toward Public Health & Safe Society
행사안내
2008 KIT국제 심포지움 개최
- 작성자양승원
- 조회수2717
- 등록일2009.04.29
Korean Society of Toxicology
/Environmental Mutagens and Carcinogens
2008 Spring Symposium
Friday, May 23, 2008
Seoul National University, Hoam Convention Center
Predictive Toxicology & Drug Discovery
08:00 ~ 09:00 Registration
09:00 ~ 09:10 Opening Address Dr. Sang-Seop Han
(President, KSOT/KEMS)
Welcome Address To be announced
Congratulatory Remarks Dr. Myung-Haing Cho (Director General, NITR/KFDA)
Session I. Predictive Toxicology & Bioinformatics
Part I.
Chairperson: Sang Geon Kim, PhD (Seoul National University, Korea)
09:10 ~ 09:50 Toxicology in 21st Century: Paradigm Shift to Systems and Predictive Toxicology and OECD/IPCS(WHO) Roles
Sue Nie Park, PhD (NITR/KFDA, Korea)
09:50 ~ 10:30 Bioinformatics for Predictive Toxicogenomics
Ju Han Kim, MD, PhD (Seoul National University, Korea)
10:30 ~ 10:50 Coffee Break
Part II.
Chairperson: Sue Nie Park, PhD (NITR/KFDA, Korea)
10:50 ~ 11:30 Understanding and Implication of Meta-analysis
Chun-Bae Kim, MD, PhD (Yonsei University, Korea)
11:30 ~ 12:10 The Role of Metabonomics in Exploring Drug Toxicity
and Diseases
Yulan Wang, PhD
(Wuhan Institute of Physics and Mathematics, China)
12:10 ~ 12:50 Computational Modeling Approaches toward System Biology:
in vivo (hydrazine and ANIT) & in vitro (amino acids) studies
Jung-Wook Bang, PhD (Imperial College London, UK)
12:50 ~ 13:00 Remarks
13:00 ~ 14:00 Lunch
평의원회
14:00 ~ 15:00 Poster Presentation
Session II. 7th KIT Symposium: Frontier Drug Discovery
Part I: Frontier Research for Drug Discovery
Chairperson: Seokjoo Yoon, PhD (Korea Institute of Toxicology)
15:00 ~ 15:40 An Array of FDA Efforts in Toxicogenomics
Weida Tong, PhD (NCTR/FDA, USA)
15:40 ~ 16:20 DWP418, A Novel Cancer Gene Therapeutic with an Emerging Role in Tumor Tissue Penetration
Chae-Ok Yun, PhD (Yonsei University, Korea)
16:20 ~ 16:40 Coffee Break
Part II: Case Review, Success Stories in Drug Development
Chairperson: Kyung Won Seo, PhD (Korea Food and Drug Administration)
16:40 ~ 17:20 Developmental Strategy of Udenafil, a Novel PDE5 Inhibitor
Byoung Ok Ahn, DVM, PhD
(Dong-A Pharmaceutical Co. Ltd, Korea)
17:20 ~ 18:00 Development and Licensing of Ilaprazole
Lee Jun Yeoun. (Il Yang Pharmaceutical Co., Korea)
18:00 ~ 18:10 Closing Remarks
18:10 ~ Reception
/Environmental Mutagens and Carcinogens
2008 Spring Symposium
Friday, May 23, 2008
Seoul National University, Hoam Convention Center
Predictive Toxicology & Drug Discovery
08:00 ~ 09:00 Registration
09:00 ~ 09:10 Opening Address Dr. Sang-Seop Han
(President, KSOT/KEMS)
Welcome Address To be announced
Congratulatory Remarks Dr. Myung-Haing Cho (Director General, NITR/KFDA)
Session I. Predictive Toxicology & Bioinformatics
Part I.
Chairperson: Sang Geon Kim, PhD (Seoul National University, Korea)
09:10 ~ 09:50 Toxicology in 21st Century: Paradigm Shift to Systems and Predictive Toxicology and OECD/IPCS(WHO) Roles
Sue Nie Park, PhD (NITR/KFDA, Korea)
09:50 ~ 10:30 Bioinformatics for Predictive Toxicogenomics
Ju Han Kim, MD, PhD (Seoul National University, Korea)
10:30 ~ 10:50 Coffee Break
Part II.
Chairperson: Sue Nie Park, PhD (NITR/KFDA, Korea)
10:50 ~ 11:30 Understanding and Implication of Meta-analysis
Chun-Bae Kim, MD, PhD (Yonsei University, Korea)
11:30 ~ 12:10 The Role of Metabonomics in Exploring Drug Toxicity
and Diseases
Yulan Wang, PhD
(Wuhan Institute of Physics and Mathematics, China)
12:10 ~ 12:50 Computational Modeling Approaches toward System Biology:
in vivo (hydrazine and ANIT) & in vitro (amino acids) studies
Jung-Wook Bang, PhD (Imperial College London, UK)
12:50 ~ 13:00 Remarks
13:00 ~ 14:00 Lunch
평의원회
14:00 ~ 15:00 Poster Presentation
Session II. 7th KIT Symposium: Frontier Drug Discovery
Part I: Frontier Research for Drug Discovery
Chairperson: Seokjoo Yoon, PhD (Korea Institute of Toxicology)
15:00 ~ 15:40 An Array of FDA Efforts in Toxicogenomics
Weida Tong, PhD (NCTR/FDA, USA)
15:40 ~ 16:20 DWP418, A Novel Cancer Gene Therapeutic with an Emerging Role in Tumor Tissue Penetration
Chae-Ok Yun, PhD (Yonsei University, Korea)
16:20 ~ 16:40 Coffee Break
Part II: Case Review, Success Stories in Drug Development
Chairperson: Kyung Won Seo, PhD (Korea Food and Drug Administration)
16:40 ~ 17:20 Developmental Strategy of Udenafil, a Novel PDE5 Inhibitor
Byoung Ok Ahn, DVM, PhD
(Dong-A Pharmaceutical Co. Ltd, Korea)
17:20 ~ 18:00 Development and Licensing of Ilaprazole
Lee Jun Yeoun. (Il Yang Pharmaceutical Co., Korea)
18:00 ~ 18:10 Closing Remarks
18:10 ~ Reception
